Table 1 Characteristics of study patients (N = 65)
n (%) | |
|---|---|
Agea, years | 66 (58–76) |
Survival timeb, days | 19 (11–32) |
Sex | |
Male | 34 (52.3) |
Female | 31 (47.7) |
Primary cancer site | |
Lung | 16 (24.6) |
Gastrointestinal | 13 (20.0) |
Pancreas | 11 (16.9) |
Hepatobiliary | 10 (15.4) |
Others | 15 (23.1) |
ECOG performance status | |
2-3 | 44 (67.7) |
4 | 21 (32.3) |
Symptom presence | |
Fever | 24 (36.9) |
Current infection | 29 (44.6) |
Anorexia | 59 (90.8) |
Dysphagia | 24 (36.9) |
Dyspnea on exertion | 15 (23.1) |
Uncontrolled pain (NRS ≥ 4) | 31 (47.7) |
Palliative prognostic score | |
0-5.5 | 25 (38.5) |
5.6-11.0 | 24 (36.9) |
11.1-17.5 | 16 (24.6) |
Laboratory findingsa (reference range) | |
Bilirubin, mg/dL (0.2-1.2) | 0.6 (0.3-1.2) |
Creatinine, mg/dL (0.5-1.2) | 0.6 (0.4-0.9) |
Lactate dehydrogenase, U/L (200–485) | 557 (427–776) |
Uric acid, mg/dL (2.5-8.3) | 3.7 (2.6-6.0) |
Albumin, g/dL (3.5-5.2) | 3.0 (2.6-3.3) |
C-reactive protein, mg/dL (< 0.5) | 16.3 (4.0-74.5) |
Vitamin C, μg/mL (1.9-15.0) | 0.44 (< 0.03-0.89) |
Oxidative stressc, U.F. (160–310) | 412.9 (305.1-539.2) |